Literature DB >> 29298870

Proton-pump inhibitors and increased gastric cancer risk: time-related biases.

Samy Suissa1,2, Alain Suissa3.   

Abstract

Entities:  

Keywords:  gastric cancer

Mesh：

Substances：

Year:  2018        PMID： 29298870     DOI： 10.1136/gutjnl-2017-315729

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.

Authors:  Dag Holmberg; Fredrik Mattsson; Shaohua Xie; Eivind Ness-Jensen; Hashem El-Serag; Jesper Lagergren
Journal:  J Gastroenterol       Date:  2022-10-18       Impact factor: 6.772

Review 2.  Characteristics and predictors of gastric cancer after Helicobacter pylori eradication.

Authors:  Satoki Shichijo; Yoshihiro Hirata
Journal:  World J Gastroenterol       Date:  2018-05-28       Impact factor: 5.742

3.  Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.

Authors:  Yan Xie; Benjamin Bowe; Yan Yan; Hong Xian; Tingting Li; Ziyad Al-Aly
Journal:  BMJ       Date:  2019-05-29

4.  Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis.

Authors:  Daniel Segna; Nele Brusselaers; Damian Glaus; Niklas Krupka; Benjamin Misselwitz
Journal:  Therap Adv Gastroenterol       Date:  2021-11-10       Impact factor: 4.409

5.  Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy.

Authors:  Flor Navarro; Noelia Casares; Celia Martín-Otal; Aritz Lasarte-Cía; Marta Gorraiz; Patricia Sarrión; Diana Llopiz; David Reparaz; Nerea Varo; Juan Roberto Rodriguez-Madoz; Felipe Prosper; Sandra Hervás-Stubbs; Teresa Lozano; Juan José Lasarte
Journal:  Oncoimmunology       Date:  2022-05-01       Impact factor: 7.723
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.